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Abstract Mucolipin-1 (MLN1) is a membrane protein with
homology to the transient receptor potential channels and other
non-selective cation channels. It is encoded by the MCOLN1
gene, which is mutated in patients with mucolipidosis type IV
(MLIV), an autosomal recessive disease that is characterized by
severe abnormalities in neurological development as well as by
ophthalmologic defects. At the cellular level, MLIV is associ-
ated with abnormal lysosomal sorting and tra⁄cking. Here we
identify the channel function of human MLN1 and characterize
its properties. MLN1 represents a novel Ca2+-permeable chan-
nel that is transiently modulated by changes in [Ca2+]. It is also
permeable to Na+ and K+. Large unitary conductances were
measured in the presence of these cations. With its Ca2+ per-
meability and modulation by [Ca2+], MLN1 could play a major
role in Ca2+ transport regulating lysosomal exocytosis and po-
tentially other phenomena related to the tra⁄cking of late endo-
somes and lysosomes.
/ 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Most of the stages of the endocytotic/exocytotic cycles, in-
cluding exocytosis of lysosomes, are Ca2þ-regulated phenom-
ena. Ca2þ release from late endosomal/lysosomal luminal
compartments is required for fusion of these organelles [1^3]
but the channels underlying this process remain elusive. Ly-
sosomal channels may also contribute to the Ca2þ-triggered
exocytosis of lysosomes in secretory and other cells. A poten-
tial candidate for such functions is mucolipin-1 (MLN1), a
membrane protein encoded by the MCOLN1 gene that we
and others recently cloned and found to be mutated in pa-
tients with mucolipidosis type IV (MLIV) [4^6]. MLIV is an
autosomal recessive disease [7^9] that is characterized by se-
vere abnormalities in neurological development as well as by
ophthalmologic defects. It usually presents during the ¢rst
year of life with severe mental retardation and delayed motor
milestones. MLIV is unique among the mucolipidoses in that
it appears to result from a disruption in sorting and/or trans-
port along the late endocytotic pathway [10^12]. MLN1
shares sequence homology and membrane topological features
with the transient receptor potential channels and other non-
selective cation channels [13^18]. Here we identify the channel
function of human MLN1 and characterize its properties.
2. Materials and methods
2.1. Expression of MLN1 in oocytes
MCOLN1 cDNA (GenBank accession number AF287269) was syn-
thesized by reverse transcription of total RNA from normal human
¢broblasts. The 2025 bp sequence includes a 1740 bp open reading
frame. The cDNA was cloned into the mammalian expression vector
pSV-Sport1 (Gibco BRL). A C-terminal green £uorescent protein
(GFP) fusion construct was generated by the in frame insertion of
the GFP domain from pEGFP-C1 into the pSV-MLN1 construct.
Speci¢c details of the plasmid construction are available from the
authors. Capped RNA was synthesized from linearized pSV-MLN1
templates using the mMessage mMachine In Vitro Transcription Kit
(Ambion) and modi¢ed with the Poly(A)Tailing Kit (Ambion). Oo-
cytes at stage V^VI were isolated from Xenopus laevis and injected
with 50 nl H2O containing 50 ng of MLN1 cRNA. Equal amounts of
H2O were injected into control oocytes.
2.2. Fluorescence measurements and detection of MLN1 expression in
oocytes
The MLN1 protein was visualized in oocytes by GFP £uorescence.
Fluorescent images were collected and analyzed using a Zeiss micro-
scope with £uorescence attachment, digital camera and ImagePro
software. The lysosome red £uorescent probe, Lysotracker DND99
(Molecular Probes), was used to assess the distribution of lysosome-
related structures in oocytes. The oocytes were treated for 15 min with
50 nM of the probe immediately before freezing and slicing them.
2.3. Electrophysiological measurements
Patch-clamp methodologies were employed for measurement of sin-
gle channel currents using cell-attached or excised membrane patches
[17,18]. Patch pipettes were ¢lled with a solution containing in mM
(unless otherwise speci¢ed): 100 KCl, 0.1 CaCl2, 10 HEPES, pH 7.5.
When ¢lled with this external solution, the pipette tip resistances were
typically 5^10 M6. Seals with resistances of s 5 G6 were employed
in single channel experiments, and currents were measured with an
integrating patch-clamp ampli¢er. Single channel currents were ¢l-
tered at 3^10 kHz through an 8-pole Bessel ¢lter. The bath solution
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contained, unless otherwise speci¢ed: 100 mM KCl, 0.1 WM CaCl2, 10
mM HEPES, and 5 mM EGTA, pH 7.5.
2.4. Data acquisition and analysis
Voltage stimuli were applied and currents digitized (50^200 Ws per
point) and analyzed using a PC, a Digidata converter, and programs
based on pClamp. The probability of channel opening (Po) was cal-
culated from 1^2 min segments of current records. The Goldman^
Hodgkin^Katz equation was used to calculate the permeability ratios
between Naþ (PNa) and Kþ (PK): Erev =RT/F ln [PNa/PK], where Erev
is the change in reversal potential measured when Kþ is replaced by
Naþ in the pipette solution; R, T, and F are the gas constant, absolute
temperature, and Faraday constant, respectively.
2.5. Fluorescence method for measuring the release of the lysosomal
enzyme, N-acetyl-L-D-glucosaminidase (NAG)
The method is based on measuring the £uorescence of the enzyme
substrate, 4-methyl-umbelliferyl-N-acetyl-L-D-glucosamine, as previ-
ously described [19]. The amount of NAG released for each condition
is expressed as % of the total content of NAG in the cells determined
after their lysis using 0.1% Triton X-100.
3. Results and discussion
We have isolated and assembled a full-length MCOLN1
cDNA, encoding MLN1, and expressed it in Xenopus oocytes.
Ionic currents were measured in oocytes 3^5 days after injec-
tions with synthetic RNA (cRNA) encoding full-length
MLN1.
Although there are no published reports on the localization
of endogenous MLN1 in mammalian cells, it is presumed that
the protein should be mainly expressed in lysosomal and late
endosomal membranes, given the cellular defects in MLIV.
Thus we ¢rst examined the levels and cellular distribution of
MLN1 in oocytes using GFP-tagged MLN1. We injected
GFP-tagged MLN1 cRNA into oocytes and 3^5 days later
prepared frozen sections of the oocytes and visualized them
using £uorescence microscopy. There were GFP-labeled
MLN1-containing £uorescent structures in the cytoplasm of
many of the oocytes that co-localized with lysosomes stained
with the lysosome-selective probe Lysotracker DND99, but a
substantial number of the oocytes also showed peripheral dis-
tribution of MLN1 in clusters near or on the plasma mem-
brane (see Fig. 5). The appearance of a fraction of MLN1 on
the plasma membrane may be due to overexpression, or per-
haps to constitutive lysosomal exocytosis, a phenomenon that
has been previously described in both secretory and non-se-
cretory cells [19^21].
In single channel studies using 100 mM KCl (Fig. 1a) or
NaCl (Fig. 1b) in the pipette solution we observed distinctive,
relatively long channel openings and closings in MLN1-ex-
pressing oocytes (n=85). The amplitudes of the inward cur-
rents increased linearly at more negative voltages but the am-
plitudes of the outward currents at positive voltages (not
shown) were much smaller than the inward currents. Such
activity was absent in water-injected oocytes (n=54) and oo-
cytes expressing other proteins (n=82). The unitary conduc-
tances determined from the slopes of the current-voltage rela-
tions (Fig. 1c) were 92.4P 10.2 pS (n=15) for Kþ and
82.6P 8.5 pS (n=15) for Naþ in the presence of 100 mM of
either of the cations. The slope conductances and reversal
potentials were determined in the presence of Kþ on one
side of excised patches and Naþ on the other side (i.e. under
biionic conditions) to characterize the selectivity and relative
permeabilities of the MLN1 channels. The permeability ratio,
PNa/PK, was 0.94P 0.04 (n=5). To assess the contribution of
anion £uxes to the MLN1 channel currents, we varied the
content of anions and cations in the solutions on both sides
of the inside-out patches and found that Cl3 in£ux or e¥ux
does not contribute to the observed currents.
We treated the oocytes with actinomycin D (10 Wg/ml), a
widely used approach to distinguish cloned from endogenous
channels, and observed no e¡ects on the MLN1 channel ac-
tivities. All of these data support the notion that the observed
channel activity does not result from upregulation or modu-
lation of channels endogenous to the oocytes.
We also studied MLN1 single channel currents in the pres-
ence of divalent cations. The channel activity usually occurred
in bursts of brief openings (Fig. 2a^c). The current amplitudes
measured at de¢ned voltages (Fig. 2a^c) and the current^vol-
tage relationships (Fig. 2d) for Ca2þ di¡er slightly from those
for Sr2þ and Ba2þ. The Ca2þ conductance, measured over the
linear voltage range (370^120 mV), 34.4P 3.5 pS (n=6), was
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Fig. 1. Monovalent cation currents in oocytes injected with MLN1
cRNA. Current traces were recorded in cell-attached patches in the
presence of 100 mM KCl (a) or 100 mM NaCl (b) in the pipette so-
lution. Downward de£ections represent channel openings. The cur-
rent records were taken at 380 mV (top traces), 3100 mV (middle
traces) or 3120 mV (bottom traces) in panels a and b. Current^vol-
tage relations in the presence of 100 mM KCl (open squares) or
100 mM NaCl (closed triangles) in the pipette solution are shown in
panel c.
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Fig. 2. Divalent cation currents mediated by MLN1. MLN1 single
channel currents were recorded in the presence of 100 mM CaCl2
(a), BaCl2 (b) and SrCl2 (c) in the external pipette solution, respec-
tively. The current traces were taken at 390 mV (top traces) or
3120 mV (bottom traces) in panels a, b and c. The current^voltage
relations for Ca2þ (open squares), Sr2þ (closed circles), and Ba2þ
(closed triangles) are shown in panel d.
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slightly smaller than that of Sr2þ (37.2 P 2.9 pS, n=4) but that
of Ba2þ was the largest, 44.6 P 4.2 pS, n=6.
Although some of the described properties of the MLN1
channel are similar to those of the polycystin L (PCL) and
polycystin-2 (PC2) channels that we have previously charac-
terized [17,18] there are some noteworthy di¡erences. The
membrane topology of MLN1 is similar to these recently
cloned members of the polycystin family of proteins, most
strikingly to PC2 with its long extracellular loop between
the ¢rst and second transmembrane domains. The long open-
ings of the MLN1 channels are comparable to those of PCL.
However, the unitary conductance of the latter is nearly 40%
larger than that of MLN1. The conductance and kinetics of
the MLN1 channel also di¡er from those of PC2 in that PC2
has a substantially higher conductance for Kþ than for Naþ,
while MLN1 has similar conductances for both cations.
Moreover, the MLN1 channel does not display £ickery burst
kinetics, a property characteristic of the PC2 channel [18].
The observation of MLN1 channel activity on the plasma
membrane, despite the presence of a late endosomal/lysosomal
targeting motif in MLN1, is not completely unexpected.
Although one possible explanation may be related to over-
expression of MLN1 in the oocytes, many studies on mast
cells and other specialized secretory cells have shown that a
portion of the lysosomes that are near the cell surface can be
exocytosed constitutively as well as in a Ca2þ-dependent man-
ner. In recent studies it was found that this is probably a
ubiquitous phenomenon and that a similar lysosomal exocy-
tosis occurs in ¢broblasts as well as epithelial and other non-
secretory cells [19^21]. The exocytotic process in these non-
secretory cells is also stimulated by increases in intracellular
Ca2þ, and the lysosomes behave as Ca2þ-regulated exocytotic
vesicles. Lysosomal exocytosis was triggered by treating ¢bro-
blasts and other cells with Ca2þ ionophores such as ionomycin
as well as with receptor agonists and other agents inducing
Ca2þ in£ux or release from intracellular stores, thereby in-
creasing the level of cytosolic Ca2þ (Cai) [19]. It was shown
that at least 10^20% of the lysosomes in ¢broblasts are exo-
cytosed and that not only are their luminal contents released
in the extracellular spaces, but integral membrane proteins
speci¢c for the lysosomes also appear on the plasma mem-
brane during this process [19]. It is possible that, like these
integral membrane proteins, MLN1 can also reside, at least
transiently, on the plasma membrane (see Fig. 5).
To investigate this possibility we tested the e¡ects of ion-
omycin on MLN1 channel activities and found that the activ-
ity of the MLN1 channels was higher in cell-attached patches
of oocytes pretreated with this Ca2þ ionophore than in those
of untreated oocytes (Fig. 3a,b). Ionomycin was used at the
same concentrations and under similar conditions as in pre-
vious studies on cultured cells [19]. In cell-attached patches,
however, the ionomycin-induced Ca2þ in£ux could cause stim-
ulation of intracellular messengers and related signaling path-
ways with potential impact on the activity of the MLN1 chan-
nels. Therefore, we carried out studies in inside-out patches
where [Ca2þ] on the cytosolic sides of the excised patches
could be controlled. An elevation in [Ca2þ] on the intracellu-
lar sides of the patches from 0.1 to 1 WM mediated a transient
increase in the open state probability (Po) (Fig. 3c) suggesting
that the MLN1 channel can be modulated at least transiently
by changes in Cai. Po usually returned to the baseline level 3^
5 min after this rise of channel activity. In some patches only
one channel was activated, while in other patches more than
one channel current level was observed, particularly during
the transient phase of activation. We estimated the average
number of channel current levels observed during the di¡erent
phases of channel modulation by changes in Cai and found a
transient increase after elevation of Cai.
To explore the contribution of increased recruitment of
channels to the plasma membrane during activation, we
then compared the MLN1 channel activities in inside-out
patches excised from untreated oocytes with those from ion-
omycin-pretreated oocytes (Fig. 4a,b). These studies were con-
ducted in the presence of basal [Ca2þ] on the cytosolic patch
sides, 0.1 WM. In patches of untreated oocytes usually only
one or two MLN1 channel current levels were observed (Fig.
4a), while two or three channels were frequently available in
patches from oocytes treated with ionomycin (Fig. 4b). Po
was slightly higher in patches of ionomycin-pretreated than
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Fig. 3. Modulation of MLN1 channels by changes in cytosolic Ca2þ
(Cai). Current traces recorded at 3110 mV in cell-attached patches
of untreated oocytes (a) are compared with those in oocytes pre-
treated for 15 min with 10 WM ionomycin (b). Changes in the chan-
nel open state probability (Po) ( P S.E.M., n=4) mediated by eleva-
tion of Cai from 0.1 to 1 WM in inside-out patches excised from
untreated oocytes are shown in panel c.
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Fig. 4. E¡ects of the Ca2þ ionophore, ionomycin, on MLN1 chan-
nel and lysosomal exocytosis. Current traces taken at 3110 mV in
the presence of 0.1 WM Cai in inside-out patches excised from un-
treated oocytes (a) or from oocytes pretreated for 15 min with 10
WM ionomycin (b). The di¡erences between the average numbers of
channel current levels (CCL) ( P S.E.M., n=25) observed in inside-
out patches excised from untreated oocytes (0) or oocytes treated
for 5, 10, 15 and 30 min with 10 WM ionomycin as marked under
each bar are shown in panel c. Only patches containing at least one
channel current level were analyzed. Excised patches that did not
contain functioning channels were not taken into account due to
the uncertainties about potential channel rundown phenomena. The
amount of NAG (PS.E.M., n=5) released into the bath solution
from untreated oocytes (dashed line) and from oocytes treated for
5, 10, 15 and 30 min with 10 WM ionomycin (solid line) is shown in
panel d. The released amount of NAG is expressed as % of its total
content in the cells as explained in Section 2.
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in untreated oocytes (data not shown) but the average number
of channel current levels increased substantially with pro-
longed treatments with ionomycin (Fig. 4c). These results,
particularly those shown in Fig. 4b,c, strongly suggest that
the Ca2þ ionophore promotes MLN1 translocation to the
plasma membrane. To investigate whether this process is as-
sociated with translocation of the lysosomes toward the cell
periphery resulting in fusion with the cell membrane and re-
lease of the lysosomal content during exocytosis, we measured
the amount of NAG released from the oocytes (Fig. 4d).
NAG is a lysosome-speci¢c enzyme whose activity has previ-
ously been characterized in Xenopus oocytes [22]. The release
of this enzyme, which was assessed using a £uorescent sub-
strate, was stimulated by pretreatment with ionomycin (Fig.
4d) con¢rming that the Ca2þ ionophore promotes the exocy-
tosis of the MLN1-containing lysosomes. Similar to the elec-
trophysiological data shown in Fig. 4c the amount of the
released lysosomal enzyme increased substantially with pro-
longed treatments with ionomycin (Fig. 4d).
In support of these data we found an increased distribution
of GFP-tagged MLN1 at the plasma membrane after iono-
mycin pretreatment (Fig. 5a,b). This pretreatment also stimu-
lated the translocation to the plasma membrane of the lyso-
somes stained with the red £uorescent probe, Lysotracker
DND99 (Fig. 5c,d). In many areas the GFP-tagged MLN1
co-localized with the Lysotracker-stained lysosomal structures
in the cytoplasm or at the plasma membrane. The £uorescence
images displayed in Fig. 5e,f that have been taken at a higher
magni¢cation con¢rm that ionomycin stimulates substantially
the translocation of the GFP-labeled MLN1 to the plasma
membrane.
The MLN1 channels may be involved in previously de-
scribed Ca2þ transport across lysosomal membranes [23] as
well as in Ca2þ-dependent fusion between the lysosomal and
plasma membrane during the exocytotic stage of the mem-
brane tra⁄cking process. It has been shown that lysosomal
exocytosis plays a role in membrane resealing related to
wound healing [20], and it is likely that it also functions in
the removal of cellular debris near sites of cellular damage
and in membrane repair. It is possible that disturbance in
these processes could be implicated in both corneal opaci¢ca-
tion [24] and achlorhydria [25], two hallmarks of MLIV. Fur-
ther studies are necessary to clarify the potential role of
MLN1 in lysosome tra⁄cking toward cell periphery and to
verify whether its de¢ciency can explain the juxtanuclear dis-
tribution of the lysosomes observed in ¢broblasts and other
cells of patients with MLIV.
Additional functional characterization of MLN1 could also
help to assess its potential contribution to Ca2þ release from
late endosomes/lysosomes, a step required for the fusion be-
tween these organelles that is likely disturbed in MLIV. The
fusion between endosomes and lysosomes preceding the deliv-
ery of lipids and other materials to the latter type of catabolic
organelles depends on a local source of Ca2þ, their luminal
compartments. Numerous studies have shown that the fusion
between yeast vacuoles, which represent the lysosomal equiv-
alent in yeast, as well as between mammalian late endosomes
and lysosomes occurs in several stages, including priming and
docking [1,2], but the ¢nal phase of membrane fusion can
only be triggered when Ca2þ is transported from the organ-
ellar lumen to the cytosol leading to modulation of calmodu-
lin and probably other Ca2þ-binding proteins. It has been
suggested that the transport of Ca2þ across the membranes
of these organelles is mediated by an as yet unidenti¢ed Ca2þ-
permeable channel(s) or other speci¢c types of transporters
[1^3]. Activation of the high conductance MLN1 channels
in these membranes could produce large increases in Ca2þ
in the cytosolic spaces between the organelles, thus triggering
their fusion.
With its high Kþ conductance MLN1 may also contribute
to Kþ transport across the membranes of the Ca2þ-containing
organelles. Previous reports support the importance of Kþ
in£ux pathways in the endoplasmic reticulum (ER) that are
coupled to Ca2þ release as part of a highly cooperative ion
exchange mechanism [26,27]. Counter-currents carried by Kþ
probably maintain the electroneutrality of the ER membrane
system during Ca2þ release. The MLN1 channel could play a
similar role in counter-current mechanisms in endosomes and
lysosomes.
Thus MLN1 represents a novel Ca2þ-permeable channel
related to endosomal/lysosomal tra⁄cking. MLN1 may take
Fig. 5. Translocation of MLN1-containing lysosomes to plasma
membrane stimulated by ionomycin. Frozen sections of the oocytes
were prepared 5 days after the injection and the distribution of the
GFP £uorescence (a,b) and of the Lysotracker (c,d) in untreated
(a,c) or ionomycin-treated (10 WM for 15 min) oocytes (b,d) was ob-
served. The same area of an untreated oocyte is shown in panels a
and c, and the same area of an ionomycin-treated oocyte is shown
in panels b and d. The magni¢cation for all the images shown in
a^d is 100U. The images in panels e and f have been taken at a
higher magni¢cation, 400U. They show the distribution of GFP-la-
beled MLN1 in untreated oocytes (e) and in oocytes treated for 15
min with 10 WM ionomycin (f). Photos are representative of at least
six oocytes from three di¡erent batches for each of the conditions.
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part in the control of Ca2þ-dependent stages of the endocy-
totic/exocytotic cycles as well as in pathophysiological pro-
cesses involving lysosomal aggregation, proteolysis and stor-
age. Abnormalities in each of these processes could be
implicated in the pathogenesis of MLIV.
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